Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Merck
Federal Trade Commission
Fish and Richardson
Express Scripts
QuintilesIMS
Citi
Harvard Business School
Moodys

Generated: June 20, 2018

DrugPatentWatch Database Preview

Claims for Patent: 6,133,418

« Back to Dashboard

Summary for Patent: 6,133,418
Title: Synthetic peptide inhibitors of HIV transmission
Abstract:The present invention relates to peptides which exhibit potent anti-retroviral activity. The peptides of the invention comprise DP-178 (SEQ ID:1) ptide corresponding to amino acids 638 to 673 of the HIV-1.sub.LAI gp41 protein, and fragments, analogs and homologs of DP-178. The invention further relates to the uses of such peptides as inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells.
Inventor(s): Bolognesi; Dani Paul (Durham, NC), Matthews; Thomas James (Durham, NC), Wild; Carl T. (Durham, NC)
Assignee: Duke University (Durham, NC)
Application Number:08/554,616
Patent Claims: 1. A peptide having the formula

in which amino acid residues are presented by the single-letter code wherein:

X is an amino group, an acetyl group, a 9-fluorenylmethoxy-carbonyl group, or a hydrophobic group; and

Z is a carboxyl group, an amido group, or a hydrophobic group.

2. A peptide having the formula

in which amino acid residues are presented by the single-letter code wherein:

X is an acetyl group; and

Z is an amido group.

3. A pharmaceutical composition comprising an effective amount of the peptide of claim 2 and a pharmaceutically acceptable carrier or excipient.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cerilliant
Chinese Patent Office
US Army
Chubb
Daiichi Sankyo
Express Scripts
Teva
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.